President Joe Biden’s Inflation Reduction Act gave the government sweeping new power to set the price Medicare will pay for ...
The Biden administration is flexing some federal muscle in its push for lower drug prices, warning pharmaceutical companies ...
Medicare negotiations of prescription drug prices could have cut seniors' out-of-pocket costs by nearly a quarter had the program been in effect in 2021, according to an analysis Mathematica provided ...
The Biden administration unveiled a new framework outlining the factors federal agencies should consider in determining ...
Only one company has responded to an FTC demand for several drugmakers to delist dozens of patents that were improperly or ...
The first 10 drugs included in the Medicare Drug Price Negotiation Program created by the Inflation Reduction Act (IRA) were ...
Uncertainty about the impact of Medicare drug price negotiations and the Federal Trade Commission’s (FTC) scrutiny of M&A deals in the sector remain overhangs.
We all know that policymakers are increasingly focused on lowering drug costs. From the Inflation Reductions Act's Medicare price negotiations (aka price controls) to the recent proposals directed at ...
In terms of therapeutic breakthroughs, Isasi suggested that the drug price negotiation program’s current structure is an effective deterrent from drugmakers’ low-impact profit chasing. “In ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
Through the deal, AbbVie gains Elahere that is approved for ovarian cancer patients who have received previous therapies, and ...
Yes! I want to get the latest chemistry news from C&EN in my inbox every week. ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly ...
